Literature DB >> 33748085

Printability, Durability, Contractility and Vascular Network Formation in 3D Bioprinted Cardiac Endothelial Cells Using Alginate-Gelatin Hydrogels.

Christopher David Roche1,2, Poonam Sharma1,2,3, Anthony Wayne Ashton1, Chris Jackson1, Meilang Xue1, Carmine Gentile1,2.   

Abstract

BACKGROUND: 3D bioprinting cardiac patches for epicardial transplantation are a promising approach for myocardial regeneration. Challenges remain such as quantifying printability, determining the ideal moment to transplant, and promoting vascularisation within bioprinted patches. We aimed to evaluate 3D bioprinted cardiac patches for printability, durability in culture, cell viability, and endothelial cell structural self-organisation into networks.
METHODS: We evaluated 3D-bioprinted double-layer patches using alginate/gelatine (AlgGel) hydrogels and three extrusion bioprinters (REGEMAT3D, INVIVO, BIO X). Bioink contained either neonatal mouse cardiac cell spheroids or free (not-in-spheroid) human coronary artery endothelial cells with fibroblasts, mixed with AlgGel. To test the effects on durability, some patches were bioprinted as a single layer only, cultured under minimal movement conditions or had added fibroblast-derived extracellular matrix hydrogel (AlloECM). Controls included acellular AlgGel and gelatin methacryloyl (GELMA) patches.
RESULTS: Printability was similar across bioprinters. For AlgGel compared to GELMA: resolutions were similar (200-700 μm line diameters), printing accuracy was 45 and 25%, respectively (AlgGel was 1.7x more accurate; p < 0.05), and shape fidelity was 92% (AlgGel) and 96% (GELMA); p = 0.36. For durability, AlgGel patch median survival in culture was 14 days (IQR:10-27) overall which was not significantly affected by bioprinting system or cellular content in patches. We identified three factors which reduced durability in culture: (1) bioprinting one layer depth patches (instead of two layers); (2) movement disturbance to patches in media; and (3) the addition of AlloECM to AlgGel. Cells were viable after bioprinting followed by 28 days in culture, and all BIO X-bioprinted mouse cardiac cell spheroid patches presented contractile activity starting between day 7 and 13 after bioprinting. At day 28, endothelial cells in hydrogel displayed organisation into endothelial network-like structures.
CONCLUSION: AlgGel-based 3D bioprinted heart patches permit cardiomyocyte contractility and endothelial cell structural self-organisation. After bioprinting, a period of 2 weeks maturation in culture prior to transplantation may be optimal, allowing for a degree of tissue maturation but before many patches start to lose integrity. We quantify AlgGel printability and present novel factors which reduce AlgGel patch durability (layer number, movement, and the addition of AlloECM) and factors which had minimal effect on durability (bioprinting system and cellular patch content).
Copyright © 2021 Roche, Sharma, Ashton, Jackson, Xue and Gentile.

Entities:  

Keywords:  3D bioprinting; alginate; bioink; durability; gelatin; hydrogel; printability; spheroids

Year:  2021        PMID: 33748085      PMCID: PMC7968457          DOI: 10.3389/fbioe.2021.636257

Source DB:  PubMed          Journal:  Front Bioeng Biotechnol        ISSN: 2296-4185


  29 in total

Review 1.  Filling the Gaps between the In Vivo and In Vitro Microenvironment: Engineering of Spheroids for Stem Cell Technology.

Authors:  Carmine Gentile
Journal:  Curr Stem Cell Res Ther       Date:  2016       Impact factor: 3.828

2.  Improved accuracy and precision of bioprinting through progressive cavity pump-controlled extrusion.

Authors:  Philipp Fisch; Martin Holub; Marcy Zenobi-Wong
Journal:  Biofabrication       Date:  2020-12-17       Impact factor: 9.954

3.  Revisiting Cardiac Cellular Composition.

Authors:  Alexander R Pinto; Alexei Ilinykh; Malina J Ivey; Jill T Kuwabara; Michelle L D'Antoni; Ryan Debuque; Anjana Chandran; Lina Wang; Komal Arora; Nadia A Rosenthal; Michelle D Tallquist
Journal:  Circ Res       Date:  2015-12-03       Impact factor: 17.367

Review 4.  Assessment methodologies for extrusion-based bioink printability.

Authors:  Gregory Gillispie; Peter Prim; Joshua Copus; John Fisher; Antonios G Mikos; James J Yoo; Anthony Atala; Sang Jin Lee
Journal:  Biofabrication       Date:  2020-02-19       Impact factor: 9.954

5.  Bioprinting 3D microfibrous scaffolds for engineering endothelialized myocardium and heart-on-a-chip.

Authors:  Yu Shrike Zhang; Andrea Arneri; Simone Bersini; Su-Ryon Shin; Kai Zhu; Zahra Goli-Malekabadi; Julio Aleman; Cristina Colosi; Fabio Busignani; Valeria Dell'Erba; Colin Bishop; Thomas Shupe; Danilo Demarchi; Matteo Moretti; Marco Rasponi; Mehmet Remzi Dokmeci; Anthony Atala; Ali Khademhosseini
Journal:  Biomaterials       Date:  2016-09-05       Impact factor: 12.479

6.  Use of GelMA for 3D printing of cardiac myocytes and fibroblasts.

Authors:  Priyanka Koti; Narine Muselimyan; Eman Mirdamadi; Huda Asfour; Narine A Sarvazyan
Journal:  J 3D Print Med       Date:  2019-01-15

7.  3D Printing of Personalized Thick and Perfusable Cardiac Patches and Hearts.

Authors:  Nadav Noor; Assaf Shapira; Reuven Edri; Idan Gal; Lior Wertheim; Tal Dvir
Journal:  Adv Sci (Weinh)       Date:  2019-04-15       Impact factor: 16.806

8.  Sodium Alginate/Gelatine Hydrogels for Direct Bioprinting-The Effect of Composition Selection and Applied Solvents on the Bioink Properties.

Authors:  Dorota Bociaga; Mateusz Bartniak; Jacek Grabarczyk; Karolina Przybyszewska
Journal:  Materials (Basel)       Date:  2019-08-22       Impact factor: 3.623

9.  Cardiac spheroids as promising in vitro models to study the human heart microenvironment.

Authors:  Liudmila Polonchuk; Mamta Chabria; Laura Badi; Jean-Christophe Hoflack; Gemma Figtree; Michael J Davies; Carmine Gentile
Journal:  Sci Rep       Date:  2017-08-01       Impact factor: 4.379

10.  Omentum support for cardiac regeneration in ischaemic cardiomyopathy models: a systematic scoping review.

Authors:  Hogan Wang; Christopher D Roche; Carmine Gentile
Journal:  Eur J Cardiothorac Surg       Date:  2020-12-01       Impact factor: 4.191

View more
  5 in total

Review 1.  Myocardial infarction from a tissue engineering and regenerative medicine point of view: A comprehensive review on models and treatments.

Authors:  Gozde Basara; Gokhan Bahcecioglu; S Gulberk Ozcebe; Bradley W Ellis; George Ronan; Pinar Zorlutuna
Journal:  Biophys Rev (Melville)       Date:  2022-08-30

Review 2.  An Overview of Extracellular Matrix-Based Bioinks for 3D Bioprinting.

Authors:  Haonan Wang; Huaqing Yu; Xia Zhou; Jilong Zhang; Hongrui Zhou; Haitong Hao; Lina Ding; Huiying Li; Yanru Gu; Junchi Ma; Jianfeng Qiu; Depeng Ma
Journal:  Front Bioeng Biotechnol       Date:  2022-05-11

Review 3.  Current state and future of 3D bioprinted models for cardiovascular research and drug development.

Authors:  Liudmila Polonchuk; Carmine Gentile
Journal:  ADMET DMPK       Date:  2021-08-25

4.  Cardiac Patch Transplantation Instruments for Robotic Minimally Invasive Cardiac Surgery: Initial Proof-of-concept Designs and Surgery in a Porcine Cadaver.

Authors:  Christopher D Roche; Gautam R Iyer; Minh H Nguyen; Sohaima Mabroora; Anthony Dome; Kareem Sakr; Rohan Pawar; Vincent Lee; Christopher C Wilson; Carmine Gentile
Journal:  Front Robot AI       Date:  2022-01-18

Review 5.  Taking It Personally: 3D Bioprinting a Patient-Specific Cardiac Patch for the Treatment of Heart Failure.

Authors:  Niina Matthews; Berto Pandolfo; Daniel Moses; Carmine Gentile
Journal:  Bioengineering (Basel)       Date:  2022-02-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.